Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Competing Timescales Lead to Oscillations in Shear-Thickening Suspensions.

Richards JA, Royer JR, Liebchen B, Guy BM, Poon WCK.

Phys Rev Lett. 2019 Jul 19;123(3):038004. doi: 10.1103/PhysRevLett.123.038004.

PMID:
31386471
2.

A seat at the table: Exploring the experiences of underrepresented minority women in STEM graduate programs.

Guy B, Boards A.

J Prev Interv Community. 2019 Oct-Dec;47(4):354-365. doi: 10.1080/10852352.2019.1617383. Epub 2019 Jun 19.

PMID:
31215330
3.

Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults.

Pillet S, Couillard J, Trépanier S, Poulin JF, Yassine-Diab B, Guy B, Ward BJ, Landry N.

PLoS One. 2019 Jun 5;14(6):e0216533. doi: 10.1371/journal.pone.0216533. eCollection 2019.

4.

Complementary use of mass spectrometry and cryo-electron microscopy to assess the maturity of live attenuated dengue vaccine viruses.

Trauchessec M, Lambert O, Bonnafous P, Berard Y, Barriere F, Huillet C, Marco S, Sirohi D, Hedrick V, Kuhn R, Guy B, Ronzon F, Manin C.

Vaccine. 2019 Jun 12;37(27):3580-3587. doi: 10.1016/j.vaccine.2019.05.012. Epub 2019 May 20.

PMID:
31122859
5.

Constraint-Based Approach to Granular Dispersion Rheology.

Guy BM, Richards JA, Hodgson DJM, Blanco E, Poon WCK.

Phys Rev Lett. 2018 Sep 21;121(12):128001. doi: 10.1103/PhysRevLett.121.128001.

PMID:
30296154
6.

Tooth oxygen isotopes reveal Late Bronze Age origin of Mediterranean fish aquaculture and trade.

Guy SV, Thomas T, Irit Z, Andreas P, Dorit S, Omri L, Ayelet G, Guy BO.

Sci Rep. 2018 Sep 20;8(1):14086. doi: 10.1038/s41598-018-32468-1.

7.

Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.

Juraska M, Magaret CA, Shao J, Carpp LN, Fiore-Gartland AJ, Benkeser D, Girerd-Chambaz Y, Langevin E, Frago C, Guy B, Jackson N, Duong Thi Hue K, Simmons CP, Edlefsen PT, Gilbert PB.

Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8378-E8387. doi: 10.1073/pnas.1714250115. Epub 2018 Aug 20.

8.

Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014).

L'Azou M, Assoukpa J, Fanouillere K, Plennevaux E, Bonaparte M, Bouckenooghe A, Frago C, Noriega F, Zambrano B, Ochiai RL, Guy B, Jackson N.

Trans R Soc Trop Med Hyg. 2018 Apr 1;112(4):158-168. doi: 10.1093/trstmh/try037. Review.

9.

Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes.

Lecouturier V, Berry C, Saulnier A, Naville S, Manin C, Girerd-Chambaz Y, Crowe JE Jr, Jackson N, Guy B.

Vaccine. 2019 Jul 26;37(32):4601-4609. doi: 10.1016/j.vaccine.2018.04.065. Epub 2018 Apr 26.

10.

Regenerative medicine: a vehicle to infuse laboratory-bench modules into an exercise physiology curriculum.

Brown JM, Guy BS, Henderson DX, Ebert CE, Harp J, Markert CD.

Adv Physiol Educ. 2018 Mar 1;42(1):32-42. doi: 10.1152/advan.00070.2017.

11.

Biodistribution and safety of a live attenuated tetravalent dengue vaccine in the cynomolgus monkey.

Ravel G, Mantel N, Silvano J, Rogue A, Guy B, Jackson N, Burdin N.

Vaccine. 2017 Oct 13;35(43):5918-5923. doi: 10.1016/j.vaccine.2017.08.071. Epub 2017 Sep 4.

PMID:
28882438
13.

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination.

Vigne C, Dupuy M, Richetin A, Guy B, Jackson N, Bonaparte M, Hu B, Saville M, Chansinghakul D, Noriega F, Plennevaux E.

Hum Vaccin Immunother. 2017 Sep 2;13(9):2004-2016. doi: 10.1080/21645515.2017.1333211. Epub 2017 Jun 9.

14.

A recombinant live attenuated tetravalent vaccine for the prevention of dengue.

Guy B, Noriega F, Ochiai RL, L'azou M, Delore V, Skipetrova A, Verdier F, Coudeville L, Savarino S, Jackson N.

Expert Rev Vaccines. 2017 Jul;16(7):1-13. doi: 10.1080/14760584.2017.1335201. Epub 2017 Jun 7. Review. Erratum in: Expert Rev Vaccines. 2017 Jul;16(7):ix.

PMID:
28590795
15.

Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals.

Henein S, Swanstrom J, Byers AM, Moser JM, Shaik SF, Bonaparte M, Jackson N, Guy B, Baric R, de Silva AM.

J Infect Dis. 2017 Feb 1;215(3):351-358. doi: 10.1093/infdis/jiw576.

16.

Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine.

Coudeville L, Baurin N, L'Azou M, Guy B.

Vaccine. 2016 Dec 7;34(50):6426-6435. doi: 10.1016/j.vaccine.2016.08.050. Epub 2016 Sep 3.

17.

Is discussion of dengue vaccination for the 2016 Olympics necessary?

Arredondo-García JL, Hadinegoro SR, Guy B, Bouckenooghe A, Noriega F, Jackson N.

Lancet. 2016 Oct 15;388(10054):1880-1881. doi: 10.1016/S0140-6736(16)31806-2. No abstract available.

PMID:
27751394
18.

Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials.

Harenberg A, de Montfort A, Jantet-Blaudez F, Bonaparte M, Boudet F, Saville M, Jackson N, Guy B.

PLoS Negl Trop Dis. 2016 Jul 26;10(7):e0004830. doi: 10.1371/journal.pntd.0004830. eCollection 2016 Jul.

19.

Answer to the review from Halstead and Russell "Protective and immunological behavior of chimeric yellow fever dengue vaccine" (DOI 10.1016/j.vaccine.2016.02.004).

Hadinegoro SR, Arredondo-García JL, Guy B, Bouckenooghe A, Noriega F, Jackson N.

Vaccine. 2016 Aug 5;34(36):4273-4. doi: 10.1016/j.vaccine.2016.06.015. No abstract available.

PMID:
27452651
20.

Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America.

Olivera-Botello G, Coudeville L, Fanouillere K, Guy B, Chambonneau L, Noriega F, Jackson N; CYD-TDV Vaccine Trial Group.

J Infect Dis. 2016 Oct 1;214(7):994-1000. doi: 10.1093/infdis/jiw297. Epub 2016 Jul 14.

21.

[Multiple pulmonary opacities revealing toxocariasis].

Jorge D, Strady C, Guy B, Deslée G, Lebargy F, Dury S.

Rev Pneumol Clin. 2016 Aug;72(4):273-6. doi: 10.1016/j.pneumo.2016.03.004. Epub 2016 Jun 28. French.

PMID:
27368139
22.

Erratum: Towards a Unified Description of the Rheology of Hard-Particle Suspensions [Phys. Rev. Lett. 115, 088304 (2015)].

Guy BM, Hermes M, Poon WC.

Phys Rev Lett. 2016 Feb 5;116(5):059901. doi: 10.1103/PhysRevLett.116.059901. Epub 2016 Feb 2.

PMID:
26894742
23.

Clinical Reasoning: A 37-year-old man with multiple cranial neuropathies.

O'Loghlen S, Guy B, Rossiter JP, Boyd JG.

Neurology. 2016 Feb 16;86(7):e66-70. doi: 10.1212/WNL.0000000000002381. No abstract available.

24.

Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine.

Byers AM, Broder R, Haupfear K, Timiryasova TM, Hu BT, Boaz M, Warren WL, Jackson N, Moser JM, Guy B.

Open Forum Infect Dis. 2015 Nov 12;2(4):ofv172. doi: 10.1093/ofid/ofv172. eCollection 2015 Dec.

25.

Plants increase arsenic in solution but decrease the non-specifically bound fraction in the rhizosphere of an alkaline, naturally rich soil.

Obeidy C, Bravin MN, Bouchardon JL, Conord C, Moutte J, Guy B, Faure O.

Ecotoxicol Environ Saf. 2016 Apr;126:23-29. doi: 10.1016/j.ecoenv.2015.12.010. Epub 2015 Dec 18.

PMID:
26707185
26.

Hydrodynamic and Contact Contributions to Continuous Shear Thickening in Colloidal Suspensions.

Lin NY, Guy BM, Hermes M, Ness C, Sun J, Poon WC, Cohen I.

Phys Rev Lett. 2015 Nov 27;115(22):228304. Epub 2015 Nov 25.

PMID:
26650321
27.

Dengue vaccine: hypotheses to understand CYD-TDV-induced protection.

Guy B, Jackson N.

Nat Rev Microbiol. 2016 Jan;14(1):45-54. doi: 10.1038/nrmicro.2015.2. Epub 2015 Dec 7. Review.

PMID:
26639777
28.

Vaccination Against Dengue: Challenges and Current Developments.

Guy B, Lang J, Saville M, Jackson N.

Annu Rev Med. 2016;67:387-404. doi: 10.1146/annurev-med-091014-090848. Epub 2015 Oct 23. Review.

PMID:
26515983
29.

Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward.

Guy B, Briand O, Lang J, Saville M, Jackson N.

Vaccine. 2015 Dec 10;33(50):7100-11. doi: 10.1016/j.vaccine.2015.09.108. Epub 2015 Oct 20. Review.

30.

Towards a Unified Description of the Rheology of Hard-Particle Suspensions.

Guy BM, Hermes M, Poon WC.

Phys Rev Lett. 2015 Aug 21;115(8):088304. Epub 2015 Aug 20. Erratum in: Phys Rev Lett. 2016 Feb 5;116(5):059901.

PMID:
26340217
31.

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia.

Dorigatti I, Aguas R, Donnelly CA, Guy B, Coudeville L, Jackson N, Saville M, Ferguson NM.

Vaccine. 2015 Jul 17;33(31):3746-51. doi: 10.1016/j.vaccine.2015.05.059. Epub 2015 Jun 4.

32.

Accumulation of Metals and Boron in Phragmites australis Planted in Constructed Wetlands Polishing Real Electroplating Wastewater.

Sochacki A, Guy B, Faure O, Surmacz-Górska J.

Int J Phytoremediation. 2015;17(11):1068-72. doi: 10.1080/15226514.2015.1021956.

PMID:
25848916
33.

Isotopic evidence for biological nitrogen fixation by molybdenum-nitrogenase from 3.2 Gyr.

Stüeken EE, Buick R, Guy BM, Koehler MC.

Nature. 2015 Apr 30;520(7549):666-9. doi: 10.1038/nature14180. Epub 2015 Feb 16.

PMID:
25686600
34.

Site-specific characterization of envelope protein N-glycosylation on Sanofi Pasteur's tetravalent CYD dengue vaccine.

Dubayle J, Vialle S, Schneider D, Pontvianne J, Mantel N, Adam O, Guy B, Talaga P.

Vaccine. 2015 Mar 10;33(11):1360-8. doi: 10.1016/j.vaccine.2015.01.047. Epub 2015 Feb 3.

PMID:
25660649
35.

Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico.

Dayan GH, Galán-Herrera JF, Forrat R, Zambrano B, Bouckenooghe A, Harenberg A, Guy B, Lang J.

Hum Vaccin Immunother. 2014;10(10):2853-63. doi: 10.4161/21645515.2014.972131.

36.

Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment.

Monath TP, Seligman SJ, Robertson JS, Guy B, Hayes EB, Condit RC, Excler JL, Mac LM, Carbery B, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).

Vaccine. 2015 Jan 1;33(1):62-72. doi: 10.1016/j.vaccine.2014.10.004. Epub 2014 Oct 27. Review.

37.

Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein.

Glanville N, McLean GR, Guy B, Lecouturier V, Berry C, Girerd Y, Gregoire C, Walton RP, Pearson RM, Kebadze T, Burdin N, Bartlett NW, Almond JW, Johnston SL.

PLoS Pathog. 2013;9(9):e1003669. doi: 10.1371/journal.ppat.1003669. Epub 2013 Sep 26.

38.

Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore.

Harenberg A, Begue S, Mamessier A, Gimenez-Fourage S, Ching Seah C, Wei Liang A, Li Ng J, Yun Toh X, Archuleta S, Wilder-Smith A, Shek LP, Wartel-Tram A, Bouckenooghe A, Lang J, Crevat D, Caillet C, Guy B.

Hum Vaccin Immunother. 2013 Nov;9(11):2317-25. Epub 2013 Jul 9.

39.

Extremely low birthweight infants: how neonatal intensive care unit teams can reduce postnatal malnutrition and prevent growth retardation.

Loÿs CM, Maucort-Boulch D, Guy B, Putet G, Picaud JC, Haÿs S.

Acta Paediatr. 2013 Mar;102(3):242-8. doi: 10.1111/apa.12092. Epub 2012 Dec 27.

PMID:
23167480
40.

Evaluation of chimeric yellow fever 17D/dengue viral replication in ticks.

Kazimírová M, Mantel N, Raynaud S, Slovák M, Ustaniková K, Lang J, Guy B, Barban V, Labuda M.

Vector Borne Zoonotic Dis. 2012 Nov;12(11):979-85. doi: 10.1089/vbz.2011.0947. Epub 2012 Aug 27.

PMID:
22925017
41.

Validation of a liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of Sotrastaurin and its metabolite N-desmethyl-sotrastaurin in human blood.

Jakab A, Winter S, Guy B, Raccuglia M, Picard F, Kovarik JM, Chudasama J, Guttikar S, Singhal P, Kretz O.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 May 15;897:10-6. doi: 10.1016/j.jchromb.2012.03.039. Epub 2012 Apr 2.

PMID:
22541169
42.

Improvement of immunogenicity of meningococcal lipooligosaccharide by coformulation with lipidated transferrin-binding protein B in liposomes: implications for vaccine development.

Mistretta N, Guy B, Bérard Y, Dalençon F, Fratantonio O, Grégoire C, Lechevallier A, Lhéritier P, Revet L, Moreau M, Haensler J, Rokbi B.

Clin Vaccine Immunol. 2012 May;19(5):711-22. doi: 10.1128/CVI.05683-11. Epub 2012 Mar 21.

43.

Stability of yellow fever virus under recombinatory pressure as compared with chikungunya virus.

McGee CE, Tsetsarkin KA, Guy B, Lang J, Plante K, Vanlandingham DL, Higgs S.

PLoS One. 2011;6(8):e23247. doi: 10.1371/journal.pone.0023247. Epub 2011 Aug 3.

44.

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.

Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J.

Vaccine. 2011 Sep 23;29(42):7229-41. doi: 10.1016/j.vaccine.2011.06.094. Epub 2011 Jul 13. Review.

PMID:
21745521
45.

Dengue vaccine prospects: a step forward.

Guy B, Almond J, Lang J.

Lancet. 2011 Jan 29;377(9763):381-2. doi: 10.1016/S0140-6736(11)60128-1. No abstract available.

PMID:
21277439
46.
47.

Development of Sanofi Pasteur tetravalent dengue vaccine.

Guy B, Saville M, Lang J.

Hum Vaccin. 2010 Sep 16;6(9). doi: 10.4161.hv.6.9.12739. Epub 2010 Sep 16.

PMID:
20861669
48.

Strategies to improve the effect of vaccination in the elderly: the vaccine producer's perspective.

Guy B.

J Comp Pathol. 2010 Jan;142 Suppl 1:S133-7. doi: 10.1016/j.jcpa.2009.09.009. Epub 2009 Nov 7. Review.

PMID:
19897207
49.

Memory B and T cell responses induced by serotype 4 Streptococcus pneumoniae vaccines: longitudinal analysis comparing responses elicited by free polysaccharide, conjugate and carrier.

Deauvieau F, Dussurgey S, Rossignol D, de Montfort A, Burdin N, Guy B.

Vaccine. 2009 Dec 11;28(2):576-82. doi: 10.1016/j.vaccine.2009.09.081. Epub 2009 Oct 28.

PMID:
19878751
50.

[Long term renal outcome of children born preterm: a regular follow-up is needed].

Bacchetta J, Harambat J, Guy B, Putet G, Cochat P, Dubourg L.

Arch Pediatr. 2009 Sep;16 Suppl 1:S42-8. doi: 10.1016/S0929-693X(09)75300-X. French.

PMID:
19836667

Supplemental Content

Support Center